Skip to main content
. 2024 Feb 19;24:129. doi: 10.1186/s12887-024-04596-3

Table 2.

Univariate analysis of each factor with NRDS [n = 452, Mean ± SD/ Median (Q1, Q3)/ n (%)]

Statistics OR (95%CI) P-value
GA (Weeks) 35.32 ± 3.70 0.49 (0.43, 0.56) 0.000
Sex
 Females 187 (41.37%) 1.0
 Male 265 (58.63%) 1.67 (1.10, 2.52) 0.016
Birth weight (100 g) 24.25 ± 8.60 0.78 (0.74, 0.82) 0.000
CRP (mg/L) 3.13 (1.88–7.45) 1.01 (0.99, 1.02) 0.305
Total IgM (mg/L) 83.00 (61.38–114.75) 1.01 (1.00, 1.01) 0.436
WBC (*10^9/L) 13.25 (9.88–16.95) 0.94 (0.90, 0.97) 0.000
PLT (*10^9/L) 239.09 ± 68.82 0.99 (0.99, 1.00) 0.000
GDM
 No 414 (91.59%) 1.0
 Yes 38 (8.41%) 1.30 (0.65, 2.60) 0.453
Antenatal steroids
 No 124 (27.43%) 1.0
 Yes 328 (72.57%) 0.15 (0.10, 0.24) 0.000
PPROM
 No 333 (73.67%) 1.0
  < 18 h 38 (8.41%) 0.86 (0.39, 1.90) 0.716
  > 18 h 81 (17.92%) 3.48 (2.11, 5.75) 0.000
Meconium-stained amniotic fluid
 No 76 (16.81%) 1.0
 Yes 376 (83.19%) 4.71 (2.20, 10.09) 0.000

Result variables: NRDS or non-NRDS

Exposure variables: gestational age, sex, birth weight, CRP, total IgM, WBC, PLT, GDM, antenatal steroids, PPROM, meconium-stained amniotic fluid

Adjusted: None

CRP C-reactive protein, Total IgM total immunoglobulin M, WBC white blood cell count, PLT platelet count, GDM gestational diabetes mellitus, PPROM preterm premature rupture of membranes